Skip to content

Clinical trials

Phase 2/3 Myocardial Infarction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 2/3 Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20072
20081
20091
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARYx Therapeutics1
Bioheart, Inc.1
CSL Behring1
Infraredx1
Mayo Clinic1
Northwestern University1
Ohio State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction7
Atherosclerosis2
Heart Diseases2
Stroke2
Angina Pectoris1
Angina, Unstable1
Atrial Fibrillation1
Atrial Flutter1
Cardiomyopathies1
Chest Pain1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.